Abstract: Scouring refers to the lowering of the level of river bed due to water erosion. Formation of vortices in the vicinity of bridges due to obstruction caused to river flow by piers and ...
Investing.com -- Udemy (NASDAQ:UDMY) stock surged 25.7% in premarket trading Wednesday after education technology firm Coursera (NYSE:COUR) announced plans to acquire the online learning platform in ...
RPSC RAS 2024 call letters will be made available on the official website shortly. Follow the steps below to download the call letters: Step 1: Visit the official website of RPSC at rpsc.rajasthan.gov ...
ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...
Pakistan’s Higher Education Commission (HEC) has extended free Coursera access for all students under the HEC-DLSEI project until December 20, 2025 , allowing thousands of learners to continue their ...
Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...
Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...
I am a proud, unapologetic progressive with a proven track record of action to protect our most vulnerable residents, create better education for our children, and forge pathways to affordable rent ...
Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...
KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...